Video: CRESTOR(R) Reduced Risk of Blood Clots in the Veins
kellya | 30/03/2009
A new analysis from the JUPITER study shows that CRESTOR(R: 28.26, 0, 0%) (rosuvastatin calcium) 20mg significantly cut the risk of venous thromboembolism (VTE: undefined, undefined, undefined%) by 43% (p =0.007) compared to placebo among men and women with low to normal cholesterol levels and elevated high-sensitivity C-reactive protein (hsCRP).
